The ABCs of HPV – What You Need to Know About Human Papillomavirus

Human Papillomavirus (HPV) is the most common sexually transmitted infection, yet many women don’t understand what it means for their health. At North Delhi Uro & Gynae Clinic, we help women make informed decisions about HPV prevention and screening.

What is HPV?

HPV is a group of viruses belonging to the Papillomavirus family: – More than 200 types identified – Named for causing papillomas (warts) – Spreads through sexual contact – Most common STI worldwide – 80% of sexually active people infected at some point – Most infections clear naturally

HPV and Cancer Risk

Key Concept: Not All HPV Causes Cancer

Low-Risk Types (Cause Genital Warts, Not Cancer): – Types 6, 11 – Cause benign genital warts – Not associated with cancer – Treatable, uncomfortable but not dangerous

High-Risk Types (Cancer-Associated): – Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 – Type 16: Causes 50% of cervical cancers – Type 18: Causes 20% of cervical cancers – Also associated with other cancers

HPV and Cervical Cancer

Key Facts: – Nearly 100% of cervical cancers caused by high-risk HPV – Not all women with HPV get cancer – Only persistent infection (>12 months) progresses to cancer – Immune system clears infection in 90% of women – Cancer development takes 10-15+ years – This timeline allows prevention through screening

Risk Factors for HPV Progression:

Immunosuppression: – HIV/AIDS – Organ transplant recipients – Chronic diseases affecting immunity

Smoking: – Reduces immune response – Doubles cancer risk

Long-Term Oral Contraceptive Use: – Modest increased risk – Benefits usually outweigh risks

Multiple Sexual Partners: – Increased HPV exposure

Early Sexual Activity: – Cervix less mature, more vulnerable

Partner with Multiple Partners: – Increased exposure to HPV

HPV and Other Cancers

HPV also associated with: – Anal Cancer: HPV-related in 90% of cases – Oropharyngeal Cancer: HPV-related in 25-50% of cases – Penile Cancer: Less common – Vulvar and Vaginal Cancers: Small percentage

HPV Transmission

How HPV Spreads: – Sexual contact (most common) – Genital-genital contact – Oral-genital contact – Skin-to-skin contact – Rarely: Mother to baby during birth

Prevention: – Condoms: 70% reduction in transmission – Monogamous relationships: Reduce exposure – HPV vaccination: Best prevention – Abstinence: Eliminates risk

Incubation Period: – Variable: Weeks to months – Can take years to develop symptoms – Testing may show HPV without obvious signs

HPV Testing and Screening

HPV DNA Testing: – Detects presence of HPV virus – Determines if high-risk types present – More sensitive than Pap smear – Now preferred for cervical cancer screening

Testing Methods:Reflex HPV Testing: Do HPV test if Pap abnormal – Primary HPV Testing: HPV test alone (emerging standard) – HPV + Pap Co-testing: Both tests simultaneously

Screening Guidelines

Current Recommendations:

Ages 21-29: – Pap smear only every 3 years – HPV testing not recommended (high infection rate, low cancer risk) – Natural immunity usually clears infection

Ages 30-65: – Option 1: Pap smear every 3 years – Option 2: HPV test every 5 years – Option 3: Co-testing (HPV + Pap) every 5 years – Most effective: HPV-based screening

Ages >65: – Stop screening if adequate prior testing – Continue if previously abnormal

Special Populations: – HIV-positive women: Different guidelines – Immunosuppressed: More frequent screening – History of abnormal results: More frequent

What Abnormal HPV Results Mean

HPV Positive, Pap Negative: – High-risk HPV detected – Pap smear normal – Options: – Repeat HPV test in 12 months (most common) – Repeat HPV in 6 months – Colposcopy (if preferred)

HPV Positive, Pap Abnormal: – Requires colposcopy – Evaluate for precancer or cancer

HPV Negative: – Excellent prognosis – Screening interval: 5 years – Very low cancer risk

Colposcopy: – Magnified visualization of cervix – Biopsy if lesions identified – Allows diagnosis of cervical intraepithelial neoplasia (CIN)

Treatment if Precancer Found

CIN1 (Mild Dysplasia): – HPV-related changes – 70% regress spontaneously – Management: Repeat testing or surveillance – Treatment: Often not needed

CIN2/3 (Moderate-Severe Dysplasia): – Significant cancer risk (40-60% progress) – Treatment required – Options: – LEEP: Loop Electrosurgical Excision – Cold Knife Conization: Surgical removal – Laser Therapy: Destroys tissue – Cryotherapy: Freezing destroys cells – Success rate: 90-95%

Cancer: – Requires oncology consultation – Treatment: Surgery, radiation, chemotherapy – Depends on stage

HPV Vaccination

Vaccines Available:

Gardasil 9 (Most Common): – Protects against 9 HPV types – Types 6, 11 (warts) + types 16, 18, 31, 33, 45, 52, 58 – Covers 90% of cervical cancers – Most comprehensive protection

Cervarix: – Protects against types 16, 18 – Less common than Gardasil

Effectiveness: – 99% effective if given before exposure – 70-90% effective if previously exposed to some types – Best results with pre-exposure vaccination

Vaccination Schedule:

Ages 9-14: – 2-dose series (0 and 6 months) – Preferred schedule – Higher antibody response

Ages 15-26: – 3-dose series (0, 1-2 months, 6 months) – Catch-up vaccination – Vaccination recommended through age 26

Ages 27-45 (Emerging Indication): – Can still be vaccinated – May not have been exposed to all types – Individual risk assessment – FDA now allowing up to age 45

Special Populations: – Immunocompromised: 3-dose series regardless of age – Pregnant women: Defer until after pregnancy – Breastfeeding: Can vaccinate

Safety: – Most common side effect: Arm soreness – Fainting: Rare (patient counseled to sit) – Very safe overall – Extensively studied – No causal link to serious adverse events

Side Effects: – Pain at injection site – Mild fever – Temporary soreness – Serious side effects: Very rare

Vaccine Effectiveness Data: – 99% protection against vaccinated types if given before exposure – 70% protection if previously exposed – Durable protection (15+ years documented) – Protection appears lifelong based on studies

Myths and Misconceptions About HPV

Myth 1: “HPV vaccine causes infertility.” Fact: No scientific evidence supports this. Millions vaccinated with normal pregnancies.

Myth 2: “If I’m vaccinated, I don’t need screening.” Fact: Vaccine doesn’t protect against all types. Screening still needed.

Myth 3: “Only promiscuous women get HPV.” Fact: HPV very common. Can be acquired from single partner. Affects respectable women.

Myth 4: “HPV always causes cancer.” Fact: 90% of infections clear naturally. Only persistent infection risks cancer.

Myth 5: “I shouldn’t vaccinate if I’m already exposed.” Fact: Vaccine protects against other types. Still beneficial.

Myth 6: “Once vaccinated, I’m protected for life.” Fact: Long-term studies show protection, but ultimate duration not yet determined.

HPV and Sexual Health

Communicating with Partners: – Partners who contract HPV often asymptomatic – Doesn’t indicate infidelity or specific exposure time – Can be present for years before detection – Transparency important for relationship health

Partner Notification: – Many gynecologists recommend partner notification – Partners can get vaccinated if appropriate age – Awareness helps monitor health

Sexual Activity with HPV: – Can continue sexual activity – Use condoms to reduce transmission – Treat any genital warts if present – Partner at risk but risk acceptable with condoms

Genital Warts Treatment

If Low-Risk HPV Causes Warts:Cryotherapy: Freezing – Laser: Destroys warts – Topical Treatments: Imiquimod, sinecatechins – Surgical Removal: For extensive warts – Podofillin: Chemical treatment

Management: – Warts often recur (HPV remains) – Multiple treatments may be needed – Vaccination prevents future warts in vaccinated partners – Psychological support for anxiety

When to Seek Care

Contact Dr. Anju Bala For: – Abnormal Pap or HPV results – Genital warts – Desire for HPV vaccination – Questions about HPV risk – Abnormal vaginal bleeding – Suspicious lesions

Why Choose North Delhi Uro & Gynae Clinic?

  • Expert HPV knowledge
  • Comprehensive screening programs
  • Vaccination availability and counseling
  • Appropriate follow-up of abnormalities
  • Compassionate discussion of results
  • Prevention-focused approach

The Bottom Line

HPV is common and usually harmless. Regular screening and vaccination are your best defenses. Most women with HPV never develop cancer. Understanding HPV empowers you to make informed health decisions.

Stay informed. Stay protected.

Contact North Delhi Uro & Gynae Clinic: – Address: C-5, Model Town 3, New Delhi 110009 – Phone: 9910118030 – Doctor: Dr. Anju Bala (MBBS, MD, DNB) – Obstetrician & Gynaecologist

Knowledge is prevention. Prevention is health.

Recent Posts

Popular Tags

https://handle.inspiroxindia.in/plugin.php?id=IX20202021-00098&mode=body